A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures

NCT01866111 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

437

Enrollment

INDUSTRY

Sponsor class

Conditions

Partial Epilepsy

Interventions

DRUG: YKP3089
DRUG: Placebo

Sponsor

SK Life Science, Inc.